← FDA Drug Approvals (Drugs@FDA)
ALOGLIPTIN AND METFORMIN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN LABORATORIES PRIVATE LTD · Approved 2019-11-27
Drug application
- FDA Application #
ANDA210212- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ALOGLIPTIN AND METFORMIN HYDROCHLORIDE
- Generic name
- Alogliptin And Metformin Hydrochloride
- Active ingredients
- ALOGLIPTIN AND METFORMIN HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- MSN LABORATORIES PRIVATE LTD
- First approval
- 2019-11-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown